Follow the Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Market capitalisation: €13.1bn. The latest transaction was filed on 3 July 2026 (Sale). Among the most active insiders: LIU Gexin. All data is accessible without an account.
35
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€106m
34 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares Buy (bullish), based on 5 analysts. Average price target: CN¥36.21.
20Σ signal
Buys n/a€106m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,618 of 29,024 companies
51.8
score / 100
Value
33
Quality
70
FCF yld-6.8%
Earn yld3.1%
EV/EBITDA17.8x
ROE7.3%
Gross mgn80%
Net mgn13%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
75,400 shares@ HK$412.746.6% of flowShareXHKGHKEX:DA20260618E00187
25 of 35 declarations
About Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a China-based biopharmaceutical company focused on the development and manufacturing of innovative drugs. It is listed on the H-share market.